Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Autor: Collinson F; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Royle KL; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Swain J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Ralph C; Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds, UK., Maraveyas A; Academic Oncology, Faculty of Health Sciences, Hull York Medical School, Queens Centre Oncology and Haematology, Hull, UK., Eisen T; Department of Oncology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK., Nathan P; Department of Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Hertfordshire, UK., Jones R; School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Meads D; Academic Unit of Health Economics, University of Leeds, Leeds, UK., Min Wah T; Department of Diagnostic and Interventional Radiology, Leeds Teaching Hospitals Trust, Leeds, UK., Martin A; Academic Unit of Health Economics, University of Leeds, Leeds, UK., Bestall J; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Kelly-Morland C; Department of Cancer Imaging, King's College London, London, UK., Linsley C; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Oughton J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Chan K; Medical Oncology, Weston Park Cancer Hospital, Sheffield, UK., Theodoulou E; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK., Arias-Pinilla G; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK., Kwan A; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK., Daverede L; Department of Clinical Oncology, Austral University Hospital, Buenos Aires, Argentina., Handforth C; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK., Trainor S; St James's Institute of Oncology, St James's University Hospital, Leeds, UK., Salawu A; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK., McCabe C; Institute of Health Economics, University of Alberta, Edmonton, Canada., Goh V; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Buckley D; Faculty of Medicine and Health, School of Medicine, University of Leeds, Leeds, UK., Hewison J; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Gregory W; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Selby P; Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds, UK., Brown J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Brown J; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK.

Publikováno v: Health technology assessment (Winchester, England) [Health Technol Assess] 2024 Aug; Vol. 28 (45), pp. 1-171.

Sexual and reproductive health services according to adolescents boys (Bucaramanga, Colombia)

Autor: Elvinia Pinilla G, Clara M. Forero B, MaríaC. Valdivieso C, Luis C. Orozco V, Carlos Ardila, Lorena Gómez, Sandra León, Cecilia Velandia

Publikováno v: Revista Facultad Nacional de Salud Pública, Vol 27, Iss 2, Pp 164-168 (2009)

Adolescents face different dilemmas, which may happen tobe not timely solved, pose major risks to health. Objective:To characterize the basic needs and expectations of maleadolescents in Bucaramanga, Colombia, from its perception with respect to serv

Externí odkaz: https://doaj.org/article/128b42fccc314cd2907c8673e0a31b12

El diseño significativo

Autor: Mario Alberto Pinilla G.

Publikováno v: Ocupación Humana, Vol 11, Iss 3 y 4 (2006)

Este texto propone el desarrollo de un proceso de diseño enfocado en la integración de las disciplinas del diseño industrial y la terapia ocupacional. Plantea estrategias en un proyecto de diseño, para que los profesionales puedan aplicar sus

Externí odkaz: https://doaj.org/article/7e79f657f6474719a3f4a403bd7273ac

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment.

Autor: Guerrero-Ochoa P; Apoptosis, Immunity and Cancer Group, Aragón Health Research Institute (IIS-Aragón), University of Zaragoza, 50009 Zaragoza, Spain., Ibáñez-Pérez R; Apoptosis, Immunity and Cancer Group, Aragón Health Research Institute (IIS-Aragón), University of Zaragoza, 50009 Zaragoza, Spain., Berbegal-Pinilla G; Apoptosis, Immunity and Cancer Group, Aragón Health Research Institute (IIS-Aragón), University of Zaragoza, 50009 Zaragoza, Spain., Aguilar D; Department of Food Technology, Facultad de Veterinaria, Instituto Agroalimentario de Aragón-IA2, Universidad de Zaragoza-CITA, 50013 Zaragoza, Spain., Marzo I; Apoptosis, Immunity and Cancer Group, Aragón Health Research Institute (IIS-Aragón), University of Zaragoza, 50009 Zaragoza, Spain., Corzana F; Research Center for Chemical Synthesis, Department of Chemistry, University of La Rioja, 26006 Logroño, Spain., Minjárez-Sáenz M; Biocomputation and Physics of Complex Systems Institute (BIFI), University of Zaragoza, 50018 Zaragoza, Spain., Macías-León J; Biocomputation and Physics of Complex Systems Institute (BIFI), University of Zaragoza, 50018 Zaragoza, Spain., Conde B; Apoptosis, Immunity and Cancer Group, Aragón Health Research Institute (IIS-Aragón), University of Zaragoza, 50009 Zaragoza, Spain., Raso J; Department of Food Technology, Facultad de Veterinaria, Instituto Agroalimentario de Aragón-IA2, Universidad de Zaragoza-CITA, 50013 Zaragoza, Spain., Hurtado-Guerrero R; Biocomputation and Physics of Complex Systems Institute (BIFI), University of Zaragoza, 50018 Zaragoza, Spain.; ARAID Foundation, University of Zaragoza, 50018 Zaragoza, Spain.; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, 2200 Copenhagen, Denmark.; Laboratorio de Microscopías Avanzada (LMA), University of Zaragoza, 50018 Zaragoza, Spain., Anel A; Apoptosis, Immunity and Cancer Group, Aragón Health Research Institute (IIS-Aragón), University of Zaragoza, 50009 Zaragoza, Spain.

Publikováno v: Biomedicines [Biomedicines] 2022 May 24; Vol. 10 (6). Date of Electronic Publication: 2022 May 24.